Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Oncotarget logoLink to Oncotarget
. 2024 May 14;15:301. doi: 10.18632/oncotarget.28570

Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish

Chuan Yan 1,2, Qiqi Yang 1, Han-Ming Shen 3, Jan M Spitsbergen 4, Zhiyuan Gong 1,2,
PMCID: PMC11092149  PMID: 38742682

This article has been retracted: Multiple figure images in this paper were found to contain internal overlaps and duplications. Specifically, duplicate images were discovered in Figures 1B, 4A, 4B and 5C. The authors were unable to make corrections using the original data. Therefore, with the agreement of all authors, the Scientific Integrity office at Oncotarget has decided to retract this paper.

Original article: Oncotarget. 2017; 8:77096–77109. 77096-77109. https://doi.org/10.18632/oncotarget.20357


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES